Cardlytics, Inc. — Director's Dealing 2019

Oct 23, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cardlytics, Inc. (CDLX)
CIK: 0001666071
Period of Report: 2019-10-21

Reporting Person: Laube Lynne Marie (Director, Chief Operating Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-10-21	Common Stock	S	5740	$37.99	Disposed	282257	Direct
2019-10-22	Common Stock	S	639	$37.30	Disposed	20116	Indirect
2019-10-22	Common Stock	S	91	$37.93	Disposed	20025	Indirect
2019-10-22	Common Stock	S	640	$37.30	Disposed	20115	Indirect
2019-10-22	Common Stock	S	90	$37.93	Disposed	20025	Indirect

Footnotes

F1: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 5, 2018, as amended May 14, 2019.

F2: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $37.40 to $38.25, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (4), (6) and (9) to this Form 4.

F3: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the trustees of the 2013 Lynne Marie Laube GRAT fbo Keegan George Allbright (the "KGA GRAT") on May 14, 2019.

F4: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $36.76 to $37.75, inclusive.

F5: The reportable securities are held by the KGA GRAT. The Reporting Person is the trustee of the KGA GRAT.

F6: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $37.85 to $38.15, inclusive.

F7: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the trustees of the 2013 Lynne Marie Laube GRAT fbo Hayley Marie Allbright (the "HMA GRAT") on May 14, 2019.

F8: The reportable securities are held by the HMA GRAT. The Reporting Person is the trustee of the HMA GRAT.

F9: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $37.85 to $38.00, inclusive.